CDSCO Circular New Drugs Division NDCT Rules 2019 Formulation Intermediates Modified Release 24 June 2026 ⚠ Regulatory Action — Immediate Attention Required All manufacturers and importers of formulation intermediates including SR/ER/PR/DR pellets, directly compressible granules, taste-masked granules, and modified release…
Central Drugs Standard Control Organisation (CDSCO) in its latest notification has moved to tighten oversight of the booming cosmetics industry in India, issuing unambiguous guidance on what constitutes a cosmetic product, how it may lawfully be used, and what actions…
The Central Drugs Standard Control Organization (CDSCO), operating under the Directorate General of Health Services, Government of India, has issued a sweeping directive to all State and Union Territory Drug Controllers, calling for urgent and coordinated enforcement action against the…
📌 Introduction In today’s rapidly evolving pharmaceutical landscape, staying updated with drug approvals, regulatory changes, and compliance requirements is no longer optional—it’s critical. Yet, professionals across the industry—regulatory experts, manufacturers, consultants, and marketers—face a common challenge: 👉 Fragmented information spread…
Recent Post
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
